Urocortin in the synovial tissue of patients with rheumatoid arthritis

Citation
M. Uzuki et al., Urocortin in the synovial tissue of patients with rheumatoid arthritis, CLIN SCI, 100(6), 2001, pp. 577-589
Citations number
44
Categorie Soggetti
Medical Research General Topics
Journal title
CLINICAL SCIENCE
ISSN journal
01435221 → ACNP
Volume
100
Issue
6
Year of publication
2001
Pages
577 - 589
Database
ISI
SICI code
0143-5221(200106)100:6<577:UITSTO>2.0.ZU;2-H
Abstract
Urocortin is a newly identified member of the corticotropin-releasing facto r (CRF) neuropeptide family, and is known to be involved in the modulation of the inflammatory process. We examined the expression of urocortin, CRF a nd their receptors (CRF receptor; CRF-R) in the synovial tissue of patients with rheumatoid arthritis (RA) in order to study the possible biological r oles of urocortin. Synovial tissues/fluids were obtained from 38 patients w ith RA, nine patients with osteoarthritis and four with trauma. We studied the concentration of urocortin in the synovial fluid using RIA, and the exp ression of urocortin in synovial tissue using immunohistochemistry, mRNA in situ hybridization and reverse transcriptase-PCR (RT-PCR). In addition, we examined the immunolocalization of CRF and the expression of CRF-R I, -R2- alpha and -R2-beta mRNAs utilizing RT-PCR in these synovial tissues. Urocor tin concentrations in synovial fluid were higher in RA patients (79.8 +/- 1 54 pg/ml) than in control patients (12.3 +/- 4.8 pg/ml; P less than or equa l to 0.05). Urocortin immunoreactivity and mRNA signals were both detected in synovial cells, lymphocytes, fibroblasts and macrophages. The number of urocortin-positive cells in the synovium was significantly higher in RA (73 .1 +/- 32.1 cells per high-power field) than in control (18.4 +/- 10.4 cell s per high-power field) patients. In addition, both urocortin immunoreactiv ity and mRNA signals in the synovium reached maximum levels in the active s tage of RA inflammation. Moreover, the number of immunoreactive urocortin-p ositive cells was significantly correlated with the urocortin concentration in synovial fluid (r = 0.705; P < 0.001) and with histologically defined l ocal inflammatory activity (r = 0.641; P(0.001). The distribution and numbe r of immunoreactive CRF-positive cells in synovial tissue were similar to t hose of urocortin-positive cells (r = 0.701; P < 0.001). Urocortin, CRF-RI and CRF-R2-alpha mRNAs detected by RT-PCR were expressed in in the synovium of 10/10, 10/10 and 2/10 RA patients respectively, but CRF-R2-beta was not expressed. Urocortin was actively synthesized in the synovium of RA patien ts. The present study suggests that urocortin may play an important role as an autocrine and/or paracrine regulator of synovial inflammation in RA.